Home › Merck, Ferring Pharmaceuticals and the World Health Organization Working Together to Prevent Excessive Bleeding in Women after Childbirth
 

Keywords :   


Merck, Ferring Pharmaceuticals and the World Health Organization Working Together to Prevent Excessive Bleeding in Women after Childbirth

2014-04-04 14:00:00| Merck.com - Corporate News

Dateline City: WHITEHOUSE STATION, N.J. Post-partum Hemorrhage Is Leading Cause of Mothers Dying WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Ferring Pharmaceuticals today announced their collaboration with the World Health Organization (WHO) to advance a new, proprietary formulation of carbetocin, used to prevent excessive bleeding (post-partum hemorrhage) in women after childbirth, that is designed to be stable at room temperature, even in hot and tropical climates (ICH climatic zone IV). Language: English Contact: MerckMedia:Jennifer Allen Woodruff, 267-305- 3550orLainie Keller, 908-423-4187orInvestor:Carol Ferguson, 908-423-4465orFerring Media:Helen Gallagher, +41 58 301 0051orPatrick Gorman, +41 58 301 0053 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: world health working women

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
16.05Eastern North Pacific Tropical Weather Outlook
16.05Atlantic Tropical Weather Outlook
16.05The man who turned his dead father into a chatbot
16.05Firms leaving UK 'not a crisis' says stock market boss
15.05Exploring the future of agriculture
15.05American, Mexican, and Canadian cattle producers sign joint statement
15.05Attitudes EWG Verified Skincare Line Oceanly Expands with SPF Offerings
15.05Sherwin-Williams Packaging Coatings Expands Non-BPA Coatings Production in Europe
More »